A new trading day began on Monday, with Vor Biopharma Inc (NASDAQ: VOR) stock price up 14.01% from the previous day of trading, before settling in for the closing price of $0.15. VOR’s price has ranged from $0.13 to $1.87 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 62.06%. With a float of $76.80 million, this company’s outstanding shares have now reached $124.78 million.
Let’s determine the extent of company efficiency that accounts for 159 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vor Biopharma Inc (VOR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vor Biopharma Inc is 38.49%, while institutional ownership is 43.00%. The most recent insider transaction that took place on Feb 13 ’25, was worth 3,162. In this transaction CHIEF MEDICAL OFFICER of this company sold 2,227 shares at a rate of $1.42, taking the stock ownership to the 126,625 shares. Before that another transaction happened on Feb 13 ’25, when Company’s Officer proposed sale 2,227 for $1.38, making the entire transaction worth $3,073.
Vor Biopharma Inc (VOR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 62.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.83% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Here are Vor Biopharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.70, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.44 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Looking closely at Vor Biopharma Inc (NASDAQ: VOR), its last 5-days average volume was 5.92 million, which is a jump from its year-to-date volume of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 4.38%. Additionally, its Average True Range was 0.08.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 2.48%, which indicates a significant decrease from 5.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 491.78% in the past 14 days, which was higher than the 224.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7074, while its 200-day Moving Average is $0.9229. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $0.1818. Second resistance stands at $0.1912. The third major resistance level sits at $0.2023. If the price goes on to break the first support level at $0.1613, it is likely to go to the next support level at $0.1502. Now, if the price goes above the second support level, the third support stands at $0.1408.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
With a market capitalization of 21.54 million, the company has a total of 124,852K Shares Outstanding. Currently, annual sales are 0 K while annual income is -116,914 K. The company’s previous quarter sales were 0 K while its latest quarter income was -30,712 K.
